Scrip
GSK to produce paediatric vaccines at new Chinese joint venture
08 October 2009
Ian Haydock
Please Login to read the full article.
08 October 2009
Ian Haydock
GlaxoSmithKline is to set up a joint venture with the Chinese company Jiangsu Walvax Biotech for the development and manufacture of paediatric vaccines, initially GSK's measles, mumps and rubella (MMR) vaccine Priorix.
The output of the venture will be destined for the Chinese public vaccination...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Vaccine boom seen in last decade, finds WHO report
- GSK to pay €118 million for Intercell's travellers' diarrhoea and pandemic flu vaccines and access to patch technology
- GSK and Shenzhen Neptunus in £52 million flu vaccine joint venture
- Indonesia's vaccine review raises questions
COMMENT
Other Informa Comment
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
